• Something wrong with this record ?

Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma

I Kocakova, M Svoboda, K Kubosova, V Chrenko, E Roubalova, E Krejci, R Sefr, P Slampa, T Frgala, J Zaloudik

. 2007 ; 54 (5) : 447-453.

Language English Country Slovakia

This work is intended to study the effect of preoperative capecitabine and radiotherapy treatment on the levels of thymidylate synthase (TS), thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) mRNAs in rectal carcinoma. 55 patients with locally advanced rectal carcinoma (cT3-4, N0, M0 or cT2-4,N+, M0) were treated with capecitabine 825 mg/m2 twice a day and pelvic radiotherapy 1,8 Gy daily up to cumulative dose of 45 Gy, boosting up to 50,4 Gy. Patients underwent surgery 6th week after the completion of chemoradiotherapy. Biopsies of rectal carcinoma were taken before starting therapy and 14 days after its cesation. Biopsies were examined for TS, DPD and TP mRNA levels. CEA in serum was examined to monitor relapses. Both TP and TS mRNA increase two weeks after starting therapy (p<0,001). TP mRNA median levels were elevated 2,3x after starting therapy. Moreover responders exhibit 1,5x higher induction than non-responders both before and after starting therapy, but difference is significant before therapy only (p=0,017). Non-responders have most frequent TS induction. Complete remission was observed in 17% and substantial responses with microscopic residuum only in additional 19% of cases were achieved. The pathologic downstaging rate was 76%. Our data show that TS and TP mRNA are induced by preoperative chemoradiotherapy in both responders and nonresponders. TP induction is in accordance with the expected role of TP in the activation of capecitabine and the known promoting role of TP in tissue fibrosis frequently associated with tumor regression.

000      
03831naa 2200577 a 4500
001      
bmc10015032
003      
CZ-PrNML
005      
20111210175734.0
008      
100623s2007 xo e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Kocáková, Ilona, $d 1959- $7 xx0018907
245    10
$a Preoperative radiotherapy and concomitant capecitabine treatment induce thymidylate synthase and thymidine phosphorylase mRNAs in rectal carcinoma / $c I Kocakova, M Svoboda, K Kubosova, V Chrenko, E Roubalova, E Krejci, R Sefr, P Slampa, T Frgala, J Zaloudik
314    __
$a Clinic of Comprehensive Cancer Care, Laboratory of Predictive Oncology, Dept. of Clin. & Exp. Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
520    9_
$a This work is intended to study the effect of preoperative capecitabine and radiotherapy treatment on the levels of thymidylate synthase (TS), thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) mRNAs in rectal carcinoma. 55 patients with locally advanced rectal carcinoma (cT3-4, N0, M0 or cT2-4,N+, M0) were treated with capecitabine 825 mg/m2 twice a day and pelvic radiotherapy 1,8 Gy daily up to cumulative dose of 45 Gy, boosting up to 50,4 Gy. Patients underwent surgery 6th week after the completion of chemoradiotherapy. Biopsies of rectal carcinoma were taken before starting therapy and 14 days after its cesation. Biopsies were examined for TS, DPD and TP mRNA levels. CEA in serum was examined to monitor relapses. Both TP and TS mRNA increase two weeks after starting therapy (p<0,001). TP mRNA median levels were elevated 2,3x after starting therapy. Moreover responders exhibit 1,5x higher induction than non-responders both before and after starting therapy, but difference is significant before therapy only (p=0,017). Non-responders have most frequent TS induction. Complete remission was observed in 17% and substantial responses with microscopic residuum only in additional 19% of cases were achieved. The pathologic downstaging rate was 76%. Our data show that TS and TP mRNA are induced by preoperative chemoradiotherapy in both responders and nonresponders. TP induction is in accordance with the expected role of TP in the activation of capecitabine and the known promoting role of TP in tissue fibrosis frequently associated with tumor regression.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a protinádorové antimetabolity $x terapeutické užití $7 D000964
650    _2
$a karcinoembryonální antigen $x krev $7 D002272
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a deoxycytidin $x aplikace a dávkování $x terapeutické užití $7 D003841
650    _2
$a fluoruracil $x analogy a deriváty $x terapeutické užití $7 D005472
650    _2
$a genetické markery $7 D005819
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a pyrimidiny $x metabolismus $7 D011743
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a nádory rekta $7 D012004
650    _2
$a thymidinfosforylasa $x genetika $7 D013939
650    _2
$a thymidylátsynthasa $x genetika $7 D013940
700    1_
$a Svoboda, Marek, $d 1975- $7 xx0098478
700    1_
$a Kubošová, Klára. $7 _AN050584
700    1_
$a Chrenko, Vojtěch, $d 1950- $7 xx0061125
700    1_
$a Roubalova, E
700    1_
$a Krejčí, Eva $7 xx0061138
700    1_
$a Šefr, Roman, $7 xx0060111 $d 1963-
700    1_
$a Šlampa, Pavel, $d 1960- $7 mzk2004257405
700    1_
$a Frgala, Tomáš. $7 _AN026427
700    1_
$a Žaloudík, Jan, $d 1954- $7 nlk20000083399
773    0_
$t Neoplasma $w MED00003470 $g Roč. 54, č. 5 (2007), s. 447-453 $x 0028-2685
910    __
$a ABA008 $b A 1194 $y 8
990    __
$a 20100629151658 $b ABA008
991    __
$a 20100629151658 $b ABA008
999    __
$a ok $b bmc $g 750900 $s 614578
BAS    __
$a 3
BMC    __
$a 2007 $b 54 $c 5 $d 447-453 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
LZP    __
$a 2010-B1/mkme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...